Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept.
about
Comparison of performance of the Assessment of SpondyloArthritis International Society, the European Spondyloarthropathy Study Group and the modified New York criteria in a cohort of Chinese patients with spondyloarthritisWhole body MR imaging in ankylosing spondylitis: a descriptive pilot study in patients with suspected early and active confirmed ankylosing spondylitis.Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years.Extraintestinal manifestations and complications in inflammatory bowel diseases.Measurement and treatment of radiographic progression in ankylosing spondylitis: lessons learned from observational studies and clinical trials.Update on the treatment of ankylosing spondylitis.Spondyloarthritides: evolving therapiesFirst update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.ASAS/EULAR recommendations for the management of ankylosing spondylitis.Outcomes in ankylosing spondylitis: what makes the assessment of treatment effects in ankylosing spondylitis different?Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE studyImpact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis.Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides.How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?Rheumatic diseases: the effects of inflammation on bone.Pharmacological management of undifferentiated spondyloarthropathies.Management and evaluation of extra-articular manifestations in spondyloarthritisDevelopments and current pharmacotherapeutic recommendations for ankylosing spondylitis.Etanercept: long-term clinical experience in rheumatoid arthritis and other arthritis.Vertebral endplate signal changes (Modic change): a systematic literature review of prevalence and association with non-specific low back pain.Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis.Update on the use of etanercept across a spectrum of rheumatoid disorders.Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment.Population pharmacokinetics of rhTNFR-Fc in healthy Chinese volunteers and in Chinese patients with Ankylosing spondylitis.Biologic therapies for spondyloarthritis: what is new?Etanercept in the treatment of ankylosing spondylitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials, and the comparison of the Caucasian and Chinese population.Impact of biological therapy on spondyloarthritis.Etanercept: a review of its use in autoimmune inflammatory diseases.The contribution of imaging in the diagnosis and treatment of axial spondyloarthritis.EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice.Monitoring ankylosing spondylitis: clinically useful markers and prediction of clinical outcomes.Assessment of typical SpA lesions on MRI of the spine: do local readers and central readers agree in the DESIR-cohort at baseline?Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.The relationship between inflammation and new bone formation in patients with ankylosing spondylitis.Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis.Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis.Opinion: Perspectives on imaging in axial spondyloarthritis.Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.Positron emission tomography/computed tomography: a clinical tool for evaluation of enthesitis in patients with spondyloarthritides.Spinal inflammation by magnetic resonance imaging in patients with ankylosing spondylitis: association with disease activity and outcome parameters.
P2860
Q24604766-00ED969E-4A10-4790-AC09-95A4D8C83F59Q33275865-BD5431E6-D691-4AAC-B987-E039F2758876Q33766318-0B5E1201-CC7D-46B7-B0ED-8A2F3EF81507Q33866998-6BACD2D9-9689-4FFE-BA95-AA90527A7340Q34403448-840194DB-326C-4CA6-AF9C-9EDBD222CF75Q34592673-B9BBCDA8-327D-45F5-961D-7696D32C1E9CQ34613907-D5AE81E0-751C-472F-9DE0-F98825B0C738Q35636900-45ED10FB-29BD-4DD5-B271-565CF180374FQ35637012-0AD859FC-9BD5-42BD-B0A4-2861A94AF518Q35638233-BDD24F1E-76CF-4CAB-8C12-72B5EA2F3436Q36020178-A11138ED-88E9-465E-A309-7D895CB1F15EQ36235821-A0341129-6A54-4AC9-A1FC-646645EA5E32Q36245711-AECCFBDE-4FA4-4A61-B6D9-26A46CB670AEQ36292652-0F876385-06B4-4A88-9AF4-310E96BDFEB9Q36324975-B0F84962-272C-49BC-B45D-24FB800DFC99Q36349645-E27AAE97-86F8-48A0-A719-C91CE9DCA09CQ36439889-DD0853E8-BA60-4EA5-9E08-27A1C1E9BA16Q36458447-BBB37975-FB8D-409B-9560-9EF94306571DQ36847326-B3D561C6-7336-40AA-88CD-7F98EAE2BB0BQ36973337-7735AA11-1AAB-437B-A3DA-36F83EE18A42Q37215981-47CF4D18-2366-4B33-A0B2-CE1ECE8947D3Q37290628-725D5B85-70EB-4D1A-85C3-A88030764A86Q37541327-49E2166E-C4E4-4F2A-ABA1-5452A2F9F478Q37729867-ED4C377E-9142-41F6-9936-F094ECF5CABBQ38031436-7EDBEE15-5A14-4560-AD8A-7629E6194796Q38081733-F0FBBE30-7EF0-44D3-B17F-F96B84A824F0Q38218614-2E1733F5-E3E1-435F-83AB-9D5EDFB363B3Q38230740-0A333996-92F8-4C2B-AF20-AE49761292CCQ38265675-B26C105B-A816-44C8-A5A4-A61420C16555Q38402703-41240C45-A8FB-4290-98E7-34C43B7FDFEAQ38517691-071D8BDF-80EC-48EA-B89C-0C6043407C2FQ38768089-43C8D1A5-93CD-4AE4-98AF-8A5052DE123CQ39135959-A93EFFDF-3D32-4040-B4DA-3BFE68516E61Q41396084-052906B2-BED2-4257-B7F2-7B6502405C95Q41487881-28188DCF-B050-4750-8B33-F74F2D7553E1Q42597088-0F45DB3A-495E-4817-9A15-E4A5622B03C6Q42604065-34CA8889-2E23-4854-8880-ABA688010736Q43048492-641D98FC-93D4-48E7-B560-C4534C99F367Q43223418-1697B07A-49AF-4C32-88AF-13E82A351307Q48522220-D8DDEC2F-EC46-44EE-8E42-F272BE8C312B
P2860
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Magnetic resonance imaging exa ...... tor fusion protein etanercept.
@en
Magnetic resonance imaging exa ...... tor fusion protein etanercept.
@nl
type
label
Magnetic resonance imaging exa ...... tor fusion protein etanercept.
@en
Magnetic resonance imaging exa ...... tor fusion protein etanercept.
@nl
prefLabel
Magnetic resonance imaging exa ...... tor fusion protein etanercept.
@en
Magnetic resonance imaging exa ...... tor fusion protein etanercept.
@nl
P2093
P356
P1476
Magnetic resonance imaging exa ...... tor fusion protein etanercept.
@en
P2093
P304
P356
10.1002/ART.20977
P577
2005-04-01T00:00:00Z